CG
MRK icon

CFO4Life Group’s Merck MRK Stock Holding History

CFO4Life Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$290K Sell
2,411
-137
-5% -$15.8K 0.04% 167
2025
Q4 		$268K Sell
2,548
-173
-6% -$16.2K 0.04% 191
2025
Q3 		$228K Buy
+2,721
New +$224K 0.03% 205
2025
Q2 		– Sell
-2,797
Closed -$251K – 241
2025
Q1 		$251K Buy
2,797
+167
+6% +$15.6K 0.04% 175
2024
Q4 		$262K Sell
2,630
-179
-6% -$18.5K 0.05% 170
2024
Q3 		$319K Sell
2,809
-75
-3% -$8.91K 0.06% 152
2024
Q2 		$357K Buy
2,884
+251
+10% +$32.3K 0.07% 136
2024
Q1 		$347K Sell
2,633
-157
-6% -$19.4K 0.06% 138
2023
Q4 		$304K Buy
2,790
+6
+0.2% +$623 0.06% 140
2023
Q3 		$287K Sell
2,784
-5,673
-67% -$611K 0.07% 126
2023
Q2 		$976K Buy
8,457
+629
+8% +$71.4K 0.21% 55
2023
Q1 		$833K Buy
7,828
+692
+10% +$74.7K 0.19% 58
2022
Q4 		$792K Buy
+7,136
New +$729K 0.17% 71
2022
Q3 		– Sell
-2,297
Closed -$212K – 163
2022
Q2 		$212K Sell
2,297
-183
-7% -$16.2K 0.05% 133
2022
Q1 		$203K Buy
+2,480
New +$196K 0.04% 149

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CFO4Life Group's MRK Position: Q1 2026 in Review

CFO4Life Group reduced its Merck (MRK) stake by 5.4% in Q1 2026, selling an estimated $15.8K and leaving 2,411 shares worth $290K. The position accounts for 0.04% of the portfolio, ranked #167.

CFO4Life Group first reported a position in MRK in Q1 2022 and has held it in 15 quarters since. The position peaked at $976K in Q2 2023. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • CFO4Life Group held 2,411 shares of Merck worth $290K as of Q1 2026.
  • CFO4Life Group sold 137 Merck shares in Q1 2026, an estimated $15.8K.
  • Merck made up 0.04% of CFO4Life Group's portfolio in Q1 2026, its #167 holding.
  • CFO4Life Group first reported a position in Merck in Q1 2022 and has held it in 15 quarters since.
  • CFO4Life Group's Merck position peaked at $976K in Q2 2023.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on CFO4Life Group's 13F filing for Q1 2026, filed 11 May 2026.